Retatrutide is a new treatment in the fight against obesity. This novel drug, categorized as a dual GLP-1 and GIP receptor agonist, exhibits promising results in research studies. By boosting these receptors, https://siobhanrrps965520.webbuzzfeed.com/36719718/retatrutide-a-promising-new-treatment-for-obesity